Based on prior surveys, TIM4, along with TIM3, plays an essential role in the degradation of dying tumor cells via autophagy, reducing antigen presentation and impairing cytotoxic T lymphocyte (CTL) responses, creating immune tolerance, and weakening the antitumor immune response (Junjappa et al., 2019). Here, HAVCR2 is linked to neoplasm.